Pacific Biosciences of California (NASDAQ:PACB) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning. A number of other research firms also recently issued reports on PACB. Stephens restated an “overweight” rating and issued a $1.80 price target on shares […]
More Stories
Oil Falls, Stocks Jump on Renewed Hopes of Iran War Ending
By Tom Ozimek Oil prices dropped and stocks around the world rallied on April 1 on renewed hopes of a...
US Appeals Court Blocks Judge’s Rulings Against Trump Immigration Detention Policy
By Jack Phillips A U.S. appeals court on Tuesday halted a federal judge’s nationwide rulings that blocked the Trump administration...
Trump Says He’s Strongly Considering Pulling US Out of NATO
By Guy Birchall U.S. President Donald Trump said he is strongly considering withdrawing the United States from NATO, in comments...
Iran’s Top Leader Issues Statement Saying Regime Will Keep Backing Anti-Israel Forces
By Jack Phillips Iran’s top leader released a new statement on April 1 saying the Iranian regime will continue to...
Who is Jessi Draper? Know about her kissing drama with Chase McWhorter
Who is Jessi Draper? A star member of Hulu’s popular reality series, Secret Lives of Mormon Wives, has again stepped...
City Hunter 2: Release Date, Cast, Plot, and Review
Netflix has officially announced City Hunter Season 2, following the first film’s notable success. The streaming platform plans to release...